QR-koodi

Antiphospholipid antibodies as potential predictors of disease severity and poor prognosis in systemic lupus erythematosus-associated thrombocytopenia: results from a real-world CSTAR cohort study

Abstract Background To investigate the role of antiphospholipid antibodies (aPLs) in the disease severity and prognosis of SLE-related thrombocytopenia (SLE-TP). Methods This multicenter prospective study was conducted based on data from the CSTAR registry. TP was defined as a platelet count<100 × 1...

Täydet tiedot

Tallennettuna:
Päätekijät: Jun Li, Liying Peng, Lijun Wu, Yufang Ding, Xinwang Duan, Jian Xu, Wei Wei, Zhen Chen, Cheng Zhao, Min Yang, Nan Jiang, Shangzhu Zhang, Qian Wang, Xinping Tian, Mengtao Li, Xiaofeng Zeng, Yan Zhao, Jiuliang Zhao
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMC 2024-03-01
Sarja:Arthritis Research & Therapy
Aiheet:
Thrombocytopenia
Systemic Lupus Erythematosus
Antiphospholipid antibodies
Severity
Prognosis
Linkit:https://doi.org/10.1186/s13075-024-03305-w
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia